Showing results (341-350 of 5,672) with videos related to

Sort By:
Pageof 568
The Oncologist|February 21, 2002
Development of the proteasome inhibitor PS-341Julian Adams
The Oncologist|January 13, 2006
Management of gastrointestinal stromal tumors in the imatinib era: selected case studiesRobert S Benjamin, Charles D Blanke, Jean-Yves Blay, et al.
The Oncologist|January 13, 2006
A practical update on the use of bortezomib in the management of multiple myelomaJesús San Miguel, Joan Bladé, Mario Boccadoro, et al.
The Oncologist|September 2, 2025
Impact of Temporary Atezolizumab and Bevacizumab Interruption on Survival in Advanced HCC: An IMbrave150 AnalysisXiao-Qian Xu, Wei-Ming Li, Li-Chen Shi, et al.
The Oncologist|April 28, 2010
Estrogen receptor expression and docetaxel efficacy in patients with metastatic breast cancer: a pooled analysis of four randomized trialsFabrice Andre, Kristine Broglio, Lajos Pusztai, et al.
The Oncologist|April 17, 2010
The diversity of nutritional status in cancer: new insightsMariana Ramos Chaves, Carolina Boléo-Tomé, Isabel Monteiro-Grillo, et al.
The Oncologist|September 19, 2009
Update on erythropoiesis-stimulating agents and clinical trials in oncologyMatti Aapro, Jerry L Spivak
The Oncologist|September 19, 2009
Examining the involvement of erythropoiesis-stimulating agents in tumor proliferation (erythropoietin receptors, receptor binding, signal transduction), angiogenesis, and venous thromboembolic eventsJoachim Fandrey, Mario Dicato
The Oncologist|March 30, 2010
Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safetyDavid Moreno-Ramirez, Luis de la Cruz-Merino, Lara Ferrandiz, et al.
The Oncologist|March 31, 2010
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discoverySabine Tejpar, Monica Bertagnolli, Fred Bosman, et al.
Pageof 568